Coronary	O
angiography	O
done	O
demonstrated	O
significant	O
lesions	B-ety
in	I-ety
the	I-ety
mid	I-ety
portion	I-ety
of	I-ety
the	I-ety
Left	I-ety
Descending	I-ety
Coronary	I-ety
Artery	I-ety
(	O
LAD	O
)	O
and	O
the	O
proximal	O
Circumflex	O
Coronary	O
Artery	O
(	O
Cx	O
)	O
.	O

Further	O
workup	O
of	O
the	O
patient	O
demonstrated	O
multiple	B-ety
radiologic	I-ety
lesions	I-ety
consistent	O
with	O
metastases	B-ety
.	O

A	O
pelvic	O
examination	O
revealed	O
a	O
cystic	B-ety
lesion	I-ety
arising	O
from	O
her	O
cervix	O
.	O

It	O
resulted	O
in	O
disease	O
progression	O
according	O
to	O
RECIST	O
with	O
simultaneous	O
elimination	O
of	O
sorafenib	O
side	O
effects	O
such	O
as	O
rash	B-ety
and	O
hand-foot	B-ety
syndrome	I-ety
.	O

A	O
22	O
-	O
year-old	O
woman	O
,	O
without	O
any	O
formerly	O
diagnosed	O
diseases	O
,	O
presented	O
to	O
the	O
emergency	O
department	O
with	O
a	O
3	O
day	O
history	O
of	O
dyspnea	B-ety
,	O
fatigue	B-ety
and	O
central	B-ety
chest	I-ety
pain	I-ety
.	O

The	O
swelling	B-ety
was	O
non-tender	O
and	O
there	O
were	O
no	O
associated	O
skin	O
changes	O
.	O

Laboratory	O
examination	O
showed	O
leukocytosis	B-ety
,	O
anemia	B-ety
and	O
normal	O
platelet	O
counts	O
.	O

The	O
ovarian	B-ety
cyst	I-ety
size	O
had	O
not	O
changed	O
in	O
size	O
and	O
structure	O
on	O
biannual	O
transvaginal	O
ultrasound	O
(	O
TVS	O
)	O
.	O

Follow-up	O
and	O
outcomes	O
:	O
microscopic	O
examination	O
revealed	O
a	O
lymphocytic	B-ety
infiltration	I-ety
of	O
both	O
layers	O
of	O
the	O
muscularis	O
propria	O
.	O

The	O
patient	O
was	O
taken	O
for	O
surgical	O
exploration	O
and	O
staging	O
for	O
ovarian	B-ety
malignancy	I-ety
.	O

